|
Lipid and lipoprotein metabolism
Citations 321-330 of 547 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment
- Benjamin J. Ansell, Mohamad Navab, Susan Hama, Naeimeh Kamranpour, Gregg Fonarow, Greg Hough, Shirin Rahmani, Rachel Mottahedeh, Ravi Dave, Srinivasa T. Reddy, and Alan M. Fogelman
Circulation published November 24, 2003, doi:10.1161/01.CIR.0000103624.14436.4B
[Abstract]
- Articles
Lipid Lowering by Pravastatin Increases Parasympathetic Modulation of Heart Rate. G i2, a Possible Molecular Marker for Parasympathetic Responsiveness
- C. Michael Welzig, Dong-Gu Shin, Ho-Jin Park, Young-Jo Kim, J. Philip Saul, and Jonas B. Galper
Circulation published November 17, 2003, doi:10.1161/01.CIR.0000103680.61390.16
[Abstract]
- Articles
Remnant Lipoprotein-Induced Smooth Muscle Cell Proliferation Involves Epidermal Growth Factor Receptor Transactivation
- Akio Kawakami, Akira Tanaka, Tsuyoshi Chiba, Katsuyuki Nakajima, Kentaro Shimokado, and Masayuki Yoshida
Circulation published November 17, 2003, doi:10.1161/01.CIR.0000093278.75565.87
[Abstract]
- Clinical Investigations and Reports
Comparison of the Associations of Apolipoprotein B and Low-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in the Insulin Resistance Atherosclerosis Study (IRAS)
- Ken Williams, Allan D. Sniderman, Naveed Sattar, Ralph D’Agostino, Jr, Lynne E. Wagenknecht, and Steven M. Haffner
Circulation 2003;108:2312-2316; published online before print as doi:10.1161/01.CIR.0000097113.11419.9E
[Abstract]
[Full text]
- Basic Science Reports
Inactivation of Macrophage Scavenger Receptor Class B Type I Promotes Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice
- Wenwu Zhang, Patricia G. Yancey, Yan Ru Su, Vladimir R. Babaev, Yuomin Zhang, Sergio Fazio, and MacRae F. Linton
Circulation 2003;108:2258-2263; published online before print as doi:10.1161/01.CIR.0000093189.97429.9D
[Abstract]
[Full text]
- Basic Science Reports
Dose-Dependent Acceleration of High-Density Lipoprotein Catabolism by Endothelial Lipase
- Cyrille Maugeais, Uwe J.F. Tietge, Uli C. Broedl, Dawn Marchadier, William Cain, Mary G. McCoy, Sissel Lund-Katz, Jane M. Glick, and Daniel J. Rader
Circulation 2003;108:2121-2126; published online before print as doi:10.1161/01.CIR.0000092889.24713.DC
[Abstract]
[Full text]
- Articles
Comparison of the Associations of Apolipoprotein B and Low-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in the Insulin Resistance Atherosclerosis Study (IRAS)
- Ken Williams, Allan D. Sniderman, Naveed Sattar, Ralph D’Agostino, Jr, Lynne E. Wagenknecht, and Steven M. Haffner
Circulation published October 27, 2003, doi:10.1161/01.CIR.0000097113.11419.9E
[Abstract]
- Articles
Inactivation of Macrophage Scavenger Receptor Class B Type I Promotes Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice
- Wenwu Zhang, Patricia G. Yancey, Yan Ru Su, Vladimir R. Babaev, Yuomin Zhang, Sergio Fazio, and MacRae F. Linton
Circulation published October 27, 2003, doi:10.1161/01.CIR.0000093189.97429.9D
[Abstract]
- Basic Science Reports
Oral Synthetic Phospholipid (DMPC) Raises High-Density Lipoprotein Cholesterol Levels, Improves High-Density Lipoprotein Function, and Markedly Reduces Atherosclerosis in Apolipoprotein E–Null Mice
- Mohamad Navab, Susan Hama, Greg Hough, and Alan M. Fogelman
Circulation 2003;108:1735-1739; published online before print as doi:10.1161/01.CIR.0000089375.60050.35
[Abstract]
[Full text]
- Mini-Review: Expert Opinions
The Metabolic Syndrome: More Than the Sum of Its Parts?
- Muredach P. Reilly and Daniel J. Rader
Circulation 2003;108:1546-1551, doi:10.1161/01.CIR.0000088846.10655.E0
[Full text]
|
|
